Literature DB >> 20888887

The serotonin transporter gene and startle response during nicotine deprivation.

Jennifer A Minnix1, Jason D Robinson, Cho Y Lam, Brian L Carter, Jennifer E Foreman, David J Vandenbergh, Gail E Tomlinson, David W Wetter, Paul M Cinciripini.   

Abstract

Affective startle probe methodology was used to examine the effects of nicotine administration and deprivation on emotional processes among individuals carrying at least one s allele versus those with the l/l genotype of the 5-Hydroxytryptamine (Serotonin) Transporter Linked Polymorphic Region, 5-HTTLPR in the promoter region of the serotonin transporter gene [solute ligand carrier family 6 member A4 (SLC6A4) or SERT]. Smokers (n=84) completed four laboratory sessions crossing deprivation (12-h deprived vs. non-deprived) with nicotine spray (nicotine vs. placebo). Participants viewed affective pictures (positive, negative, neutral) while acoustic startle probes were administered. We found that smokers with the l/l genotype showed significantly greater suppression of the startle response when provided with nicotine vs. placebo than those with the s/s or s/l genotypes. The results suggest that l/l smokers, who may have higher levels of the serotonin transporter and more rapid synaptic serotonin clearance, experience substantial reduction in activation of the defensive system when exposed to nicotine.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20888887      PMCID: PMC3378389          DOI: 10.1016/j.biopsycho.2010.09.013

Source DB:  PubMed          Journal:  Biol Psychol        ISSN: 0301-0511            Impact factor:   3.251


  69 in total

1.  Probing picture perception: activation and emotion.

Authors:  B N Cuthbert; M M Bradley; P J Lang
Journal:  Psychophysiology       Date:  1996-03       Impact factor: 4.016

2.  Startle potentiation: shock sensitization, aversive learning, and affective picture modulation.

Authors:  M K Greenwald; M M Bradley; B N Cuthbert; P J Lang
Journal:  Behav Neurosci       Date:  1998-10       Impact factor: 1.912

3.  Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.

Authors:  K P Lesch; D Bengel; A Heils; S Z Sabol; B D Greenberg; S Petri; J Benjamin; C R Müller; D H Hamer; D L Murphy
Journal:  Science       Date:  1996-11-29       Impact factor: 47.728

4.  Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine.

Authors:  S G Gourlay; N L Benowitz
Journal:  Clin Pharmacol Ther       Date:  1997-10       Impact factor: 6.875

5.  Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response.

Authors:  K Rasmussen; M J Kallman; D R Helton
Journal:  Synapse       Date:  1997-10       Impact factor: 2.562

6.  Diazepam blocks fear-potentiated startle in humans.

Authors:  C J Patrick; B D Berthot; J D Moore
Journal:  J Abnorm Psychol       Date:  1996-02

7.  Lateralized startle probes in the study of emotion.

Authors:  M M Bradley; B N Cuthbert; P J Lang
Journal:  Psychophysiology       Date:  1996-03       Impact factor: 4.016

Review 8.  Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders?

Authors:  K P Lesch; R Mössner
Journal:  Biol Psychiatry       Date:  1998-08-01       Impact factor: 13.382

9.  Nicotine-induced limbic cortical activation in the human brain: a functional MRI study.

Authors:  E A Stein; J Pankiewicz; H H Harsch; J K Cho; S A Fuller; R G Hoffmann; M Hawkins; S M Rao; P A Bandettini; A S Bloom
Journal:  Am J Psychiatry       Date:  1998-08       Impact factor: 18.112

10.  Allelic variation of human serotonin transporter gene expression.

Authors:  A Heils; A Teufel; S Petri; G Stöber; P Riederer; D Bengel; K P Lesch
Journal:  J Neurochem       Date:  1996-06       Impact factor: 5.372

View more
  1 in total

1.  Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.

Authors:  Tae-Hwi Schwantes-An; Juan Zhang; Li-Shiun Chen; Sarah M Hartz; Robert C Culverhouse; Xiangning Chen; Hilary Coon; Josef Frank; Helen M Kamens; Bettina Konte; Leena Kovanen; Antti Latvala; Lisa N Legrand; Brion S Maher; Whitney E Melroy; Elliot C Nelson; Mark W Reid; Jason D Robinson; Pei-Hong Shen; Bao-Zhu Yang; Judy A Andrews; Paul Aveyard; Olga Beltcheva; Sandra A Brown; Dale S Cannon; Sven Cichon; Robin P Corley; Norbert Dahmen; Louisa Degenhardt; Tatiana Foroud; Wolfgang Gaebel; Ina Giegling; Stephen J Glatt; Richard A Grucza; Jill Hardin; Annette M Hartmann; Andrew C Heath; Stefan Herms; Colin A Hodgkinson; Per Hoffmann; Hyman Hops; David Huizinga; Marcus Ising; Eric O Johnson; Elaine Johnstone; Radka P Kaneva; Kenneth S Kendler; Falk Kiefer; Henry R Kranzler; Ken S Krauter; Orna Levran; Susanne Lucae; Michael T Lynskey; Wolfgang Maier; Karl Mann; Nicholas G Martin; Manuel Mattheisen; Grant W Montgomery; Bertram Müller-Myhsok; Michael F Murphy; Michael C Neale; Momchil A Nikolov; Denise Nishita; Markus M Nöthen; John Nurnberger; Timo Partonen; Michele L Pergadia; Maureen Reynolds; Monika Ridinger; Richard J Rose; Noora Rouvinen-Lagerström; Norbert Scherbaum; Christine Schmäl; Michael Soyka; Michael C Stallings; Michael Steffens; Jens Treutlein; Ming Tsuang; Tamara L Wall; Norbert Wodarz; Vadim Yuferov; Peter Zill; Andrew W Bergen; Jingchun Chen; Paul M Cinciripini; Howard J Edenberg; Marissa A Ehringer; Robert E Ferrell; Joel Gelernter; David Goldman; John K Hewitt; Christian J Hopfer; William G Iacono; Jaakko Kaprio; Mary Jeanne Kreek; Ivo M Kremensky; Pamela A F Madden; Matt McGue; Marcus R Munafò; Robert A Philibert; Marcella Rietschel; Alec Roy; Dan Rujescu; Sirkku T Saarikoski; Gary E Swan; Alexandre A Todorov; Michael M Vanyukov; Robert B Weiss; Laura J Bierut; Nancy L Saccone
Journal:  Behav Genet       Date:  2015-09-21       Impact factor: 2.805

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.